FOXM1 and cancer: CMap is a multifunctional online tool that enables users to compare gene expression signatures that arise from genetic perturbations in cancer cells (e.g., loss of FOXM1) to a large library of gene signatures that reflect the impact of small-drug inhibitors on cancer cells.